Patents by Inventor Gary L. Norman

Gary L. Norman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230341389
    Abstract: The present disclosure relates to the use of anti-KLHL12 antibodies as a clinical biomarker for diagnosing primary biliary cirrhosis (PBC), now known as primary biliary cholangitis. The disclosure further provides compositions and methods for detecting anti-KLHL12 antibodies in a biological sample.
    Type: Application
    Filed: January 7, 2022
    Publication date: October 26, 2023
    Applicant: INOVA DIAGNOSTICS, INC.
    Inventors: GARY L. NORMAN, MICHAEL MAHLER
  • Patent number: 8338117
    Abstract: The present invention is in the field of autoimmunity. More specifically, the present invention relates to the detection of autoantibodies to domain 4 of beta 2-glycoprotein I (?2-GPI) as an indicator for atherosclerosis.
    Type: Grant
    Filed: June 4, 2010
    Date of Patent: December 25, 2012
    Assignee: Inova Diagnostics, Inc.
    Inventors: G. Michael Iverson, Walter L. Binder, Gary L. Norman
  • Publication number: 20120183981
    Abstract: The present invention is in the field of diagnostics, and in particular to the early diagnosis of liver cirrhosis in a patient not known to have liver cancer by detecting and measuring circulating cartilage oligomeric matrix protein (COMP) alone or in conjunction with one or more additional liver cirrhosis biomarkers in the biological fluid of a subject.
    Type: Application
    Filed: August 30, 2010
    Publication date: July 19, 2012
    Applicant: Inova Diagnostics, Inc.
    Inventors: Gary L. Norman, Zakera Shums
  • Publication number: 20100311089
    Abstract: The present invention is in the field of autoimmunity. More specifically, the present invention relates to the detection of autoantibodies to domain 4 of beta 2-glycoprotein I (?2-GPI) as an indicator for atherosclerosis.
    Type: Application
    Filed: June 4, 2010
    Publication date: December 9, 2010
    Inventors: G. Michael IVERSON, Walter L. Binder, Gary L. Norman
  • Patent number: 7745146
    Abstract: The present invention is in the field of autoimmunity. More specifically, the present invention relates to the detection of autoantibodies to domain 4 of beta 2-glycoprotein I (?2-GPI) as an indicator for atherosclerosis.
    Type: Grant
    Filed: July 26, 2007
    Date of Patent: June 29, 2010
    Assignee: Inova Diagnostics, Inc.
    Inventors: G. Michael Iverson, Walter L. Binder, Gary L. Norman
  • Patent number: 7622268
    Abstract: The present invention provides a method for detecting autoantibodies in a subject which reacts with a GP73 antigen. Increased levels of GP73-specific autoantibodies in a sample from the subject which bind to GP73 antigen are indicative of liver disease in the subject.
    Type: Grant
    Filed: October 26, 2007
    Date of Patent: November 24, 2009
    Assignee: INOVA Diagnostics, Inc.
    Inventors: Gary L. Norman, Zakera Shums
  • Publication number: 20080166738
    Abstract: The present invention provides a method for detecting autoantibodies in a subject which reacts with a GP73 antigen. Increased levels of GP73-specific autoantibodies in a sample from the subject which bind to GP73 antigen are indicative of liver disease in the subject.
    Type: Application
    Filed: October 26, 2007
    Publication date: July 10, 2008
    Inventors: Gary L. Norman, Zakera Shums
  • Publication number: 20080153115
    Abstract: The present invention is in the field of autoimmunity. More specifically, the present invention relates to the detection of autoantibodies to domain 4 of beta 2-glycoprotein I (?2-GPI) as an indicator for atherosclerosis.
    Type: Application
    Filed: July 26, 2007
    Publication date: June 26, 2008
    Inventors: G. Michael Iverson, Walter L. Binder, Gary L. Norman